Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Chubb
Colorcon
Mallinckrodt
Johnson and Johnson
Fish and Richardson
Julphar
Federal Trade Commission
Cipla
Cantor Fitzgerald

Generated: December 11, 2017

DrugPatentWatch Database Preview

Nortriptyline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for nortriptyline hydrochloride and what is the scope of nortriptyline hydrochloride patent protection?

Nortriptyline hydrochloride
is the generic ingredient in four branded drugs marketed by Lilly, Aurolife Pharma Llc, Idt Australia Ltd, Mayne Pharma, Mylan, Taro Pharm, Teva, Mallinckrodt Llc, Ranbaxy, Pharm Assoc, Taro, and Mallinckrodt Inc, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for nortriptyline hydrochloride. Thirty-four suppliers are listed for this compound.

Pharmacology for nortriptyline hydrochloride

Medical Subject Heading (MeSH) Categories for nortriptyline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Taro PharmNORTRIPTYLINE HYDROCHLORIDEnortriptyline hydrochlorideCAPSULE;ORAL075520-003May 8, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
RanbaxyAVENTYL nortriptyline hydrochlorideSOLUTION;ORAL014685-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaNORTRIPTYLINE HYDROCHLORIDEnortriptyline hydrochlorideCAPSULE;ORAL074132-004Mar 27, 1995ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanNORTRIPTYLINE HYDROCHLORIDEnortriptyline hydrochlorideCAPSULE;ORAL074234-003Jul 26, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaNORTRIPTYLINE HYDROCHLORIDEnortriptyline hydrochlorideCAPSULE;ORAL074132-002Mar 27, 1995ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LillyAVENTYL HYDROCHLORIDEnortriptyline hydrochlorideCAPSULE;ORAL014684-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaNORTRIPTYLINE HYDROCHLORIDEnortriptyline hydrochlorideCAPSULE;ORAL074132-003Mar 27, 1995ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Idt Australia LtdNORTRIPTYLINE HYDROCHLORIDEnortriptyline hydrochlorideCAPSULE;ORAL074054-004Dec 31, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaNORTRIPTYLINE HYDROCHLORIDEnortriptyline hydrochlorideCAPSULE;ORAL073667-002Apr 11, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mallinckrodt LlcPAMELORnortriptyline hydrochlorideCAPSULE;ORAL018013-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: nortriptyline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
RanbaxyAVENTYL nortriptyline hydrochlorideSOLUTION;ORAL014685-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
LillyAVENTYL HYDROCHLORIDEnortriptyline hydrochlorideCAPSULE;ORAL014684-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Mallinckrodt IncPAMELORnortriptyline hydrochlorideSOLUTION;ORAL018012-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Mallinckrodt LlcPAMELORnortriptyline hydrochlorideCAPSULE;ORAL018013-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Mallinckrodt LlcPAMELORnortriptyline hydrochlorideCAPSULE;ORAL018013-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Mallinckrodt LlcPAMELORnortriptyline hydrochlorideCAPSULE;ORAL018013-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Mallinckrodt LlcPAMELORnortriptyline hydrochlorideCAPSULE;ORAL018013-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
LillyAVENTYL HYDROCHLORIDEnortriptyline hydrochlorideCAPSULE;ORAL014684-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
McKesson
Healthtrust
Daiichi Sankyo
US Department of Justice
US Army
Accenture
Teva
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot